S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 28 of 28

Issue Date	Title / Author(s) / Citation	File
2005-06	Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers Chung, Jae-Yong; Cho, Joo-Youn; Yu, Kyung-Sang; Kim, Jung-Ryul; Jung, Hye-Ryung; Lim, Kyoung-Soo; Jang, In-Jin; Shin, Sang-Goo Clin Pharmacol Ther. 2005 Jun;77(6):486-94.	link
2005-10	Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers Chung, Jae-Yong; Cho, Joo-Youn; Yu, Kyung-Sang; Kim, Jung-Ryul; Oh, Dal-Seok; Jung, Hye-Ryung; Lim, Kyoung-Soo; Moon, Ki-Ho; Shin, Sang-Goo; Jang, In-Jin Clin Pharmacol Ther. 2005 Oct;78(4):342-50.	link
2006-09	Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study Kim, Euitae; Yu, Kyung-Sang; Cho, Joo-Youn; Shin, Yong-Wook; Yoo, So Young; Kim, Young Youn; Jang, In-Jin; Shin, Sang-Goo; Kwon, Jun Soo Hum Psychopharmacol. 2006 Dec;21(8):519-28.	link
2006-09	Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study Kim, Euitae; Yu, Kyung-Sang; Cho, Joo-Youn; Shin, Yong-Wook; Yoo, So Young; Kim, Young Youn; Jang, In-Jin; Shin, Sang-Goo; Kwon, Jun Soo Hum Psychopharmacol. 2006 Dec;21(8):519-28.	link
2006-12	Angiotensin II type 1 receptor 1166A/C polymorphism in association with blood pressure response to exogenous angiotensin II Lim, Hyeong-Seok; Cho, Joo-Youn; Oh, Dal-Seok; Chung, Jae-Yong; Hong, Kyoung-Sup; Bae, Kyun-Seop; Yu, Kyung-Sang; Lee, Kyung-Hoon; Jang, In-Jin; Shin, Sang-Goo Eur J Clin Pharmacol. 2007 Jan;63(1):17-26. Epub 2006 Dec 5.	link
2008-03	Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects Kim, Bo-Hyung; Lim, Hyeong-Seok; Chung, Jae-Yong; Kim, Jung-Ryul; Lim, Kyoung Soo; Sohn, Dong-Ryul; Cho, Joo-Youn; Yu, Kyung-Sang; Shin, Sang-Goo; Paick, Jae-Seung; Jang, In-Jin Br J Clin Pharmacol. 2008;65(6):848-854	link
2008-03	Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects Kim, Bo-Hyung; Lim, Hyeong-Seok; Chung, Jae-Yong; Kim, Jung-Ryul; Lim, Kyoung Soo; Sohn, Dong-Ryul; Cho, Joo-Youn; Yu, Kyung-Sang; Shin, Sang-Goo; Paick, Jae-Seung; Jang, In-Jin Br J Clin Pharmacol. 2008; 65(6): 848-854	link
2008-08	Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D610 allele in healthy Korean subjects Lim, Kyoung Soo; Cho, Joo-Youn; Jang, In-Jin; Kim, Bo-Hyung; Kim, JaeWoo; Jeon, Ji-Young; Tae, Yu-Mi; Yi, SoJeong; Eum, SoYoung; Shin, Sang-Goo; Yu, Kyung-Sang* Br J Clin Pharmacol. 2008; 66(5): 660-6	link
2008-09	Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole Kwon, Jun Soo; Kim, Euitae; Kang, Do-Hyung; Choi, Jung Seok; Yu, Kyung-Sang; Jang, In-Jin; Shin, Sang-Goo Eur Neuropsychopharmacol. 2008 ;18(12):897-907.	link
2008-11	Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study Lim, Kyoung Soo; Kim, Jung-Ryul; Choi, Yun-Jung; Shin, Kwang-Hee; Kim, Kyu-Pyo; Hong, Jang-Hee; Cho, Joo-Youn; Shin, Hyun-Suk; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, O Hwan; Hwang, Dal-Mi; Kim, Jeong-Ae; Jang, In-Jin Clin Ther. 2008;30(10):1817-1830	link
2008-11	Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients Kim, Jung-Ryul; Seo, Hyo-Bum; Cho, Joo-Youn; Kang, Do-Hyung; Kim, Yong Ku; Bahk, Won-Myong; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, Jun Soo; Jang, In-Jin Br J Clin Pharmacol. 2008 ;66(6):802-10.	link
2008-11	Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients Kim, Jung-Ryul; Seo, Hyo-Bum; Cho, Joo-Youn; Kang, Do-Hyung; Kim, Yong Ku; Bahk, Won-Myong; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, Jun Soo; Jang, In-Jin Br J Clin Pharmacol. 2008;66(6):802-10	link
2009-08	Pharmacokinetics of Intravenous Piperacillin Administration in Patients Undergoing On-Line Hemodiafiltration Oh, Kook-Hwan; Kim, Chiweon; Lee, Hankyu; Lee, Hajeong; Kim, Nam Joong; Shin, Kwang-Hee; Ahn, Curie; Jang, In-Jin; Yu, Kyung-Sang; Jung, Ji Yong ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Vol.53 8; 3266-3268	DOI
2009-11	Unpredictable Pharmacokinetics of Once-Daily Intravenous Busulfan When Combined with Fludarabine in Pediatric Patients: Phase I Clinical Study for Determination of Optimal Once-Daily Busulfan Dose Using Pharmacokinetic Modeling. Lee, Ji Won; Kang, Hyoung Jin; Lee, SeungHwan; Yu, Kyung-Sang; Yuk, Yen Ju; Han, Eun Jong; Jang, In-Jin; Ahn, Hyo Seop; Shin, Hee Young; Kim, Hyery; Jang, Mi Kyoung; Kim, Nam Hee BLOOD; Vol.114 22; 486-487
2011-06	In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy Lee, Jung Pyo; Yang, Seung Hee; Kim, Dong Ki; Lee, Hajeong; Kim, Bora; Cho, Joo-Youn; Yu, Kyung-Sang; Paik, Jin Ho; Kim, Myounghee; Lim, Chun Soo; Kim, Yon Su American Journal of Physiology - Renal Physiology, Vol.300 No.6, pp.F1283-F1290	DOI
2014-03	Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug Kim, Dong Ki; Lee, Jay Wook; Shin, Kwang-Hee; Kim, Sejoong; Oh, Kook-Hwan; Kim, Myounghee; Yu, Kyung-Sang; Lee, Jung Pyo; Lim, Chun-Soo; Kim, Yon Su; Joo, Kwon Wook BMC Nephrology, 15(1):46	view file DOI
2015-08	Phase I/II study of weekly Oraxol for the second-line treatment of patients with metastatic or recurrent gastric cancer Lee, Keun-Wook; Lee, Kyung Hee; Zang, Dae Young; Park, Young Iee; Shin, Dong Bok; Kim, Jin Won; Im, Seock-Ah; Koh, Sung Ae; Yu, Kyung-Sang; Cho, Joo-Youn; Jung, Jin-A; Bang, Yung-Jue Oncologist, Vol.20 No.8, pp.896-897	DOI
2017-08	Reliable prediction of anti-diabetic drug failure using a reject option Kang, Seokho; Cho, Sung Zoon; Rhee, Su-jin; Yu, Kyung-Sang Pattern Analysis and Applications, Vol.20 No.3, pp.883-891	DOI
2019-02	A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis Kim, Yun; Rhee, Su-jin; Park, Wan Beom; Yu, Kyung-Sang; Jang, In-Jin; Lee, Seunghwan Journal of Clinical Medicine, Vol.8 No.2, p. 227	DOI
2022-01	Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole Yang, Eunsol; Kim, Seokuee; Kim, Bongtae; Kim, Boram; Kim, Yechan; Park, Sung Sup; Song, Geun Seog; Yu, Kyung-Sang; Jang, In-Jin; Lee, SeungHwan British Journal of Clinical Pharmacology	DOI
2022-01	Cytoplasmic zinc promotes IL-1 beta production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis Kim, Bonah; Kim, Hee Young; Yoon, Bo Ruem; Yeo, Jina; Jung, Ji In; Yu, Kyung-Sang; Kim, Hyeon Chang; Yoo, Su-Jin; Park, Jin Kyun; Kang, Seong Wook; Lee, Won-Woo Science Signaling, Vol.15 No.716, p. eabi7400	DOI
2022-05	Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension Rhee, Su-Jin; Shin, Seung Han; Oh, Jaeseong; Jung, Young Hwa; Choi, Chang Won; Kim, Han-Suk; Yu, Kyung-Sang Scientific Reports, Vol.12 No.1, p. 7393	DOI
2022-05	Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects Na, Joo Young; Yang, Eunsol; Kim, Jae-Hoon; Kwon, In Sun; Jin, Eun-Heui; Yu, Kyung-Sang; Kim, Jinsook; Lee, SeungHwan; Hong, Jang Hee Clinical Pharmacology in Drug Development, Vol.11 No.5, pp.615-622	DOI
2022-05	Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects Na, Joo Young; Huh, Ki Young; Yu, Kyung-Sang; Hyon, Joon Young; Koo, Hye Cheong; Lee, Jong Ho; You, Ji Chang; Chung, Jae-Yong Clinical and Translational Science, Vol.15 No.5, pp.1123-1130	DOI
2022-08	Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects Hwang, Inyoung; Lee, Sang Won; Oh, Jaeseong; Lee, SeungHwan; Jang, In-Jin; Yu, Kyung-Sang Frontiers in Pharmacology, Vol.13, p. 930615	DOI
2022-09	A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808 Chung, Tae Kyu; Lee, Hyun A.; Lee, Kyeong-Ryoon; Jang, Seong Bok; Yu, Kyung-Sang; Lee, Howard CPT: Pharmacometrics and Systems Pharmacology, Vol.11 No.9, pp.1223-1233	DOI
2022-09	Dose-dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter-2 inhibitor, in healthy subjects Hwang, Jun Gi; Lee, SeungHwan; Huh, Wan; Han, Jumi; Oh, Jaeseong; Jang, In-Jin; Yu, Kyung-Sang British Journal of Clinical Pharmacology, Vol.88 No.9, pp.4100-4110	DOI
2022-09	Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs Bae, Sungyeun; Oh, JungJin; Song, Ildae; Yu, Kyung-Sang; Lee, SeungHwan TRANSLATIONAL AND CLINICAL PHARMACOLOGY, Vol.30 No.3, pp.145-154	DOI